NCT07554677 — Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study · CancerIndex
Clinical trial · Interventional
Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study
Feasibility of a Co-designed PRe-radiotherapy Exercise Programme for People With Stage I-III Non-small Cell Lung cAnCEr: A Single-centre, Single Arm Pilot Study
The goal of this clinical trial is to understand the feasibility of a co-designed, pre-radiotherapy exercise programme for people with stage I-III non-small cell lung cancer. This involves people with lung cancer engaging in 20 minutes exercises sessions performed within the radiotherapy department and immediately before each treatment at a personalised intensity.
The main questions it aims to answer are:
To understand the acceptability of the exercise programme through monitoring recruitment rates, attendance of the exercise sessions, and adherence to prescribed exercise intensities. Adverse events will also be monitored to understand programme safety.
Follow-up qualitative interviews will be conducted with participants, their family members, and health care professionals (HCP) to further explore the acceptability of the exercise programme.
In total, participants will be invited to perform up to twenty, supervised exercise sessions scheduled immediately before each treatment within the radiotherapy department. Each exercise session will be twenty minutes in duration and will be performed on a stationary exercise bike. Regarding exercise intensity, there are four levels which may be prescribed depending on people's exercise history, baseline exercise experience, and personal preference. Participants may progress or regress exercise intensity levels throughout the programme depending on their adherence and preference.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
Participants within the experimental arm will participate in the co-designed, pre-radiotherapy exercise programme alongside treatment.
interventionNames
Other: Exercise
Radiation: radiotherapy
Primary outcomes (6)
measure
Eligibility rates
timeFrame
Screening and enrolment
description
The percentage of eligible participants identified and approached through participant screening
measure
Recruitment rate
timeFrame
Screening and recruitment
description
The total number of potential participants who were approached and agreed to participate as a percentage of the total number who were approached
Eligibility
Eligibility (as posted)
Sex
All
Minimum age
18 Years
Show eligibility criteria text
Inclusion Criteria:
* Patients with clinically or histologically confirmed NSCLC stages 1-3.
* Planned to receive treatment with curative intention radiation as primary treatment.
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
* At least 18 years of age.
* Can understand and communicate in English.
* Deemed safe to participate in moderate-intensity exercise and for ECG monitored maximal fitness test through the completion of a medical clearance form by their treating physician.
* Able to provide written and informed consent.
Exclusion Criteria:
* Unstable or new angina (diagnosed within the previous month).
* Unstable or acute heart failure, cardiomyopathy, or other uncontrolled cardiac disease (as evidenced by symptomatic fluid retention, excessive breathlessness, rapid weight gain, swollen ankles or pitting oedema) within the previous 3 months.
* Presence of new or uncontrolled cardiac arrhythmias.
* Confirmed or suspected spinal cord compression.
* Uncontrolled diabetes (e.g. medication changed within 1 month, has had episodes of hypoglycaemia during the previous 2 weeks, or hyperglycaemia which does not decrease with exercise during the previous 2 weeks).
* Is receiving combination treatment with chemotherapy or immunotherapy.
* Current active secondary malignancy other than non-melanoma skin cancer.
* Has had orthopaedic surgery within the previous 3 months on weight-bearing bones.
* Chest pain while undertaking exercise or physical activity.
* No \> Grade 2 peripheral neuropathy.
* Metastatic disease beyond localised metastatic involvement (e.g. bone or brain).
* Has discovered any abnormalities shown on the ECG monitored maximal fitness test which warrant early termination or contraindicate physical activity.
* People with living with a physical disability which would limit their ability to exercise safely on the stationary exercise bike used within this study.
* People who are non-English speakers.
* People who are pregnant.
* Patient participation in other clinical research - As an additional consideration, patients will be excluded if they are currently enrolled in an alternative exercise or physical activity study, as this may impact outcomes in both studies. However, if they have been involved in research prior to this or are currently involved in research in an unrelated area we will not immediately exclude them from trial participation. Instead, the Doctor of Philosophy (PhD) candidate, Chief investigator, and Principal investigator will discuss their involvement to determine safe and appropriate enrolment.
* Physical disability - it is with regret that we will be limited in our capacity to offer alternative exercises to accommodate people with a physical disability. To elaborate, the Belfast City Hospitals (BCH) main gym is willing to lend a stationary exercise bike to the research team in support of this study. However, due to limitations on equipment availability in the trust, and limited funding/resources to purchase equipment, people who have a physical disability which limits their capacity to exercise safely on the stationary bike will be excluded from this study. In an ideal scenario, we would also have a recumbent stationary bike to support more people with physical disability get involved within this research.
References
Publications (69)
BACKGROUNDZiolkowska-Suchanek I. Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models. Cells. 2021 Jan 12;10(1):141. doi: 10.3390/cells10010141. PMID 33445709
BACKGROUNDSeet-Lee C, Yee J, Morahan H, Ross LS, Edwards KM. The effect of aerobic exercise on tumour blood delivery: a systematic review and meta-analysis. Support Care Cancer. 2022 Nov;30(11):8637-8653. doi: 10.1007/s00520-022-07132-0. Epub 2022 Jun 2. PMID 35650456
BACKGROUNDSasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW. A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):115-24. doi: 10.1002/jcsm.12042. Epub 2015 May 11. PMID 26136187
BACKGROUNDWorld Health Organization (2023) Lung Cancer
BACKGROUNDWorld Health Organization (2018) More active people for a healthier world
BACKGROUNDWilliams, N. (2017) 'The Borg Rating of Perceived Exertion (RPE) scale ', Occupational Medicine, 67 (5), pp. 404-405.
BACKGROUNDVinod SK, Hau E. Radiotherapy treatment for lung cancer: Current status and future directions. Respirology. 2020 Nov;25 Suppl 2:61-71. doi: 10.1111/resp.13870. Epub 2020 Jun 9. PMID 32516852
BACKGROUNDViamonte SG, Joaquim AV, Alves AJ, Vilela E, Capela A, Ferreira C, Duarte BF, Rato ND, Teixeira MP, Tavares A, Santos M, Ribeiro F. Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk: A Randomized Clinical Trial. JAMA Cardiol. 2023 Dec 1;8(12):1119-1128. doi: 10.1001/jamacardio.2023.3558. PMID 37819656
BACKGROUNDUnited Kingdom Lung Cancer Coalition (2024) Driving Quality Improvements in UK Lung Cancer: Utilising good practice and innovation to deliver optimal care and outcomes
measure
Exercise programme attendance
timeFrame
Weeks 4-8 (PReFACe exercise programme)
description
The total number of attended sessions by the total number provided
measure
Adherence to the exercise programme
timeFrame
Weeks 4-8 (PReFACe exercise programme)
description
Monitoring the participants ability to complete the advised duration and intensity of exercise during each session (adherence is accepted if completed 75% of duration without intensity modification)
measure
Participant retention rates
timeFrame
Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
description
The number of participants available to provide outcomes at the post-intervention assessment as a percentage of the total number recruited.
measure
Adverse event Common Terminology Criteria for Adverse Events (CTCAE) v5
timeFrame
Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
description
Assess the tolerability and safety of the intervention, via recording of intervention-associated adverse events (AE). AEs will be graded according to CTCAE v.5 as:
* Grade 1 = Mild
* Grade 2 = Moderate
* Grade 3 = Severe
* Grade 4 = Life-threatening consequences
* Grade 5 = Death related to AE
Secondary outcomes (12)
measure
Change from baseline in quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30-items (EORTC QLQ-30)
timeFrame
Week 0 (baseline assessment) to week 8 (end of study assessment)
description
EORTC QLQ-30 is a reliable and validated, multidimensional quality-of-life questionnaire which is widely used in research for people with lung cancer.
The QLQ-C30 is composed of both multi-item scales and single-item measures, including:
Five functional scales:
* Physical
* Role
* Emotional
* Cognitive
* Social
Three symptoms' scales:
* Fatigue
* Nausea and Vomiting
* Pain
A Global health Status (QoL)
Six single items:
* Dyspnoea
* Insomnia
* Appetite loss
* Constipation
* Diarrhoea
* Financial difficulties
All scales and single-item measures range in score from 0 to 100. High scale scores represent a higher response level, thus:
* High scores for functional sales = high/healthy levels of functioning
* High global health status = high QoL
* High symptom scale/ single item scores = higher symptom burden
measure
Change from baseline in quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer 13 (EORTC QLQ-LC13)
timeFrame
Week 0 (baseline assessment) to week 8 (end of study assessment)
description
EORTC QLQ-LC13 is a reliable and validated, multidimensional quality-of-life questionnaire which is widely used in research for people with lung cancer.
The QLQ-LC13 incorporates one multi-item scale to assess dyspnoea, and a series of single items assessing:
* Pain
* Coughing
* Sore mouth
* Dysphagia
* Peripheral Neuropathy
* Alopecia
* Haemoptysis
All single-item measures range in score from 0 to 100 with high scale scores representing a higher response level, thus:
\- High symptom scale/ single item scores = higher symptom burden
measure
Impact of exercise programmes effect on symptom burden: Pain likert Scale
timeFrame
Week 0 (baseline assessment) to week 8 (end of study assessment)
description
Understanding the impact of the exercise programme on symptom burden on participants experience of pain using a 1-10 likert scale:
* Scores 1-3 = Mild Pain
* Scores 4-7 = Moderate pain
* Scores 8-10 = Severe pain
measure
Impact of exercise programmes effect on symptom burden: Fatigue likert Scale
timeFrame
Week 0 (baseline assessment) to week 8 (end of study assessment)
description
Understanding the impact of the exercise programme on symptom burden on participants experience of fatigue using a 1-10 likert scale:
* Scores 1-2 = No fatigue
* Scores 3-4 = Minor fatigue
* Scores 5-6 = Moderate fatigue
* Scores 7-8 = Significant fatigue
* Scores 9-10 = Extreme fatigue
measure
Impact of exercise programmes effect on symptom burden: Modified Medical Research Council (MRC) dyspnoea scale
timeFrame
Week 0 (baseline assessment), daily through PReFACe exercise programme (weeks 4-8) and end of study assessment (week 8)
description
The modified MRC dyspnoea scale is a 5-point (0-4) questionnaire that assesses a patient's breathing difficulty, or dyspnoea, during activity. Higher scores correspond with more breathlessness etc:
* grade 0 = breathless with strenuous exercise
* grade 1 = short of breath when hurrying on level ground or walking up a slight hill
* grade 2 = on level ground, I walk slower than people of my age because of breathlessness
* grade 3 = I stop for breath after walking about 100 yards or after a few minutes on level ground
* grade 4 = Too breathless to leave the house or I am breathless when dressing/undressing
measure
To assess the accessibility, acceptability and experience of the exercise programme through semi-structured qualitative interviews
timeFrame
Weeks 8-14 post-intervention follow-up period
description
Conduct of post-intervention, semi-structured, qualitative interviews with the following groups:
1. Phase 1 participants (who have completed the programme or withdrew from the programme)
2. Phase 1 participants nominated person (friend or family)
3. Healt Care Professionals (HCPs) involved/ exposed to the study
A total of 15 participants (n=5 from each group) is deemed sufficient to achieve data saturation.
Semi-structured interview schedules were pre-constructed for each group.
Interview schedules consist of open-ended questions to explore the participants/experience of the exercise programme in their own words.
No scales are used as a part of this outcome.
measure
Baseline compared to post-intervention changes in participant distress levels using the National Comprehensive Cancer Network (NCCN) Distress thermometer.
timeFrame
Baseline assessment (week 0), weekly throughout the PReFACe exercise programme (weeks 4-8) and at post-study assessment (week 8)
description
The distress thermometer is a valid, and accurate screening tool used to quickly monitor for patient's distress with advanced cancer.
The thermometer uses a 0-10 scale to measure patient distress over the past week with 0 representing no distress and 10 representing extreme distress.
The thermometer also features a "Problem List" (covering practical, family, emotional, spiritual, and physical issues) to pinpoint causes of distress for referral
measure
Change in baseline to post-intervention physical fitness: Six- minute walking test
timeFrame
Baseline assessment (week 0) and post-study assessment (week 8)
description
A well-documented, validated and standardised sub-maximal fitness test measuring the distance a person can walk on a flat, solid surface in six minutes. Participants walk back and forth along a measured track to measure total distance covered in meters within six minutes.
Greater distance covered (meters) indicate greater baseline fitness.
Greater post-test distance covered (meters) than baseline scores indicate improvements in basic mobility.
Reduced post-test distance covered (meters) than baseline scores indicate reductions in basic mobility.
measure
Change in baseline to post-intervention physical fitness: 30-second sit-to-stand
timeFrame
Baseline assessment (week 0) and post-study assessment (week 8)
description
A well-documented, validated, and standardised test to measure functional lower extremity strength. Participants perform as many sit-to-stand reps as they can within 30 seconds.
measure
Change in baseline to post-intervention physical functioning: Rockwood Clinical Frailty Scale (CFS)
timeFrame
Baseline assessment (week 0) and post-study assessment (week 8)
description
The Rockwood CFS is used as a valid assessment tool for screening frailty in older adults. This is a 1-9 scale, with higher scores indicating greater frailty:
1. Very fit
2. Well
3. Managing well
4. Vulnerable
5. Mildly frail
6. Moderately frail
7. Severely frail
8. Very severely frail 9- Terminally ill
measure
Change in baseline to post-intervention physical activity: The International Physical Activity Questionnaire - Short Form (IPAQ-SF)
timeFrame
Baseline assessment (week 0) and post-study assessment (week 8)
description
The IPAQ-SF will be used to explore the influence of the pre-radiotherapy exercise programme on the participant's weekly physical activity levels pre- and post-study. Based on results, physical activity levels based on scores can be calculated as:
1. Inactive
2. Minimally active
3. HEPA active (health enhancing physical activity; a high active category)
measure
Change in baseline to post-intervention physical activity: Huffman Exercise Satisfactions Scale
timeFrame
Baseline assessment (week 0) and post-study assessment (week 8)
description
The Huffman Exercise Satisfaction Scale was developed with stakeholders as a novel approach to measure older adults (aged ≥55 years) satisfaction with their physical activity levels.
There questionnaire measures two scales:
1. A Physical activity enjoyment scale, consisting of 8 multiple choice questions. Responses are allocated a range from 1 to 7 with higher values indicate higher levels of enjoyment of physical activity
2. Satisfaction measure, consists of 4, multiple choice questions. Responses to the satisfaction items range from 1 to 7, with higher values indicating higher levels of satisfaction with physical activity.
Mean scores are taken from each scale to total participants exercise enjoyment and satisfaction.
BACKGROUNDVarkey B. Principles of Clinical Ethics and Their Application to Practice. Med Princ Pract. 2021;30(1):17-28. doi: 10.1159/000509119. Epub 2020 Jun 4. PMID 32498071
BACKGROUNDTran DL, Kamaladasa Y, Munoz PA, Kotchetkova I, D'Souza M, Celermajer DS, Maiorana A, Cordina R. Estimating exercise intensity using heart rate in adolescents and adults with congenital heart disease: Are established methods valid? Int J Cardiol Congenit Heart Dis. 2022 Mar 26;8:100362. doi: 10.1016/j.ijcchd.2022.100362. eCollection 2022 Jun. PMID 39712058
BACKGROUNDTotton N, Lin J, Julious S, Chowdhury M, Brand A. A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020. Pilot Feasibility Stud. 2023 Nov 21;9(1):188. doi: 10.1186/s40814-023-01416-w. PMID 37990337
BACKGROUNDToohey K, Mizrahi D, Hart NH, Singh B, Lopez P, Hunter M, Newton RU, Schmitz KH, Adams D, Edbrooke L, Hayes S. Exercise in cancer care for people with lung cancer: A narrative synthesis. J Sci Med Sport. 2025 Jan;28(1):16-25. doi: 10.1016/j.jsams.2024.08.002. Epub 2024 Aug 8. PMID 39155211
BACKGROUNDTivey A, Ullah M, Beech A, Ng C, Cove-Smith L. Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy? J Geriatr Oncol. 2020 Sep;11(7):1154-1156. doi: 10.1016/j.jgo.2020.03.002. Epub 2020 Mar 11. No abstract available. PMID 32171694
BACKGROUNDSuveg K, Plasswilm L, Iseli T, Leskow P, Fischer GF, Putora PM. Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review. Cancers (Basel). 2022 Mar 23;14(7):1617. doi: 10.3390/cancers14071617. PMID 35406388
BACKGROUNDSkivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061. PMID 34593508
BACKGROUNDSia J, Szmyd R, Hau E, Gee HE. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Front Cell Dev Biol. 2020 Feb 13;8:41. doi: 10.3389/fcell.2020.00041. eCollection 2020. PMID 32117972
BACKGROUNDRockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489-95. doi: 10.1503/cmaj.050051. PMID 16129869
BACKGROUNDRiba MB, Donovan KA, Ahmed K, Andersen B, Braun I, Breitbart WS, Brewer BW, Corbett C, Fann J, Fleishman S, Garcia S, Greenberg DB, Handzo GF, Hoofring LH, Huang CH, Hutchinson S, Johns S, Keller J, Kumar P, Lahijani S, Martin S, Niazi SK, Pailler M, Parnes F, Rao V, Salman J, Scher E, Schuster J, Teply M, Usher A, Valentine AD, Vanderlan J, Lyons MS, McMillian NR, Darlow SD. NCCN Guidelines(R) Insights: Distress Management, Version 2.2023. J Natl Compr Canc Netw. 2023 May;21(5):450-457. doi: 10.6004/jnccn.2023.0026. PMID 37156476
BACKGROUNDPiraux E, Caty G, Aboubakar Nana F, Reychler G. Effects of exercise therapy in cancer patients undergoing radiotherapy treatment: a narrative review. SAGE Open Med. 2020 Jun 17;8:2050312120922657. doi: 10.1177/2050312120922657. eCollection 2020. PMID 32595968
BACKGROUNDPinto BM, Ciccolo JT. Physical activity motivation and cancer survivorship. Recent Results Cancer Res. 2011;186:367-87. doi: 10.1007/978-3-642-04231-7_16. PMID 21113773
BACKGROUNDPenko AL, Barkley JE, Koop MM, Alberts JL. Borg scale is valid for ratings of perceived exertion for individuals with Parkinson's disease. Int J Exerc Sci. 2017 Jan 1;10(1):76-86. doi: 10.70252/RVAQ3828. eCollection 2017. PMID 28479949
BACKGROUNDPeddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2. PMID 30741408
BACKGROUNDPearson N, Naylor PJ, Ashe MC, Fernandez M, Yoong SL, Wolfenden L. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020 Oct 31;6(1):167. doi: 10.1186/s40814-020-00634-w. PMID 33292770
BACKGROUNDOrtmann BM. Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity. BMJ Oncol. 2024 Feb 1;3(1):e000154. doi: 10.1136/bmjonc-2023-000154. eCollection 2024. PMID 39886164
BACKGROUNDNorton K, Norton L, Sadgrove D. Position statement on physical activity and exercise intensity terminology. J Sci Med Sport. 2010 Sep;13(5):496-502. doi: 10.1016/j.jsams.2009.09.008. Epub 2009 Dec 10. PMID 20005170
BACKGROUNDNisar H, Sanchidrian Gonzalez PM, Brauny M, Labonte FM, Schmitz C, Roggan MD, Konda B, Hellweg CE. Hypoxia Changes Energy Metabolism and Growth Rate in Non-Small Cell Lung Cancer Cells. Cancers (Basel). 2023 Apr 26;15(9):2472. doi: 10.3390/cancers15092472. PMID 37173939
BACKGROUNDNikitara K, Odani S, Demenagas N, Rachiotis G, Symvoulakis E, Vardavas C. Prevalence and correlates of physical inactivity in adults across 28 European countries. Eur J Public Health. 2021 Oct 11;31(4):840-845. doi: 10.1093/eurpub/ckab067. PMID 34000007
BACKGROUNDNational Institute of Health, (2021). Common Terminology Criteria for Adverse Events (CTCAE)
BACKGROUNDNational Institute for Health and Care Excellence (2014) Behaviour Change: Individual Approaches
BACKGROUNDNational Data Guardian (2020) The Eight Caldicott Principles.
BACKGROUNDMuz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015 Dec 11;3:83-92. doi: 10.2147/HP.S93413. eCollection 2015. PMID 27774485
BACKGROUNDMorgan B, Hejdenberg J, Kuleszewicz K, Armstrong D, Ziebland S. Are some feasibility studies more feasible than others? A review of the outcomes of feasibility studies on the ISRCTN registry. Pilot Feasibility Stud. 2021 Nov 8;7(1):195. doi: 10.1186/s40814-021-00931-y. PMID 34749831
BACKGROUNDMoreton, R., Stutz, A., Robinson, S., Mulla, I., Winter, M., Roberts, J. & Hillsdon, M. (2018) Evaluation of the Macmillan Physical Activity Behaviour Change Care Pathway
BACKGROUNDMoreno-Arino M, Torrente Jimenez I, Cartanya Gutierrez A, Oliva Morera JC, Comet R. Assessing the strengths and weaknesses of the Clinical Frailty Scale through correlation with a frailty index. Aging Clin Exp Res. 2020 Nov;32(11):2225-2232. doi: 10.1007/s40520-019-01450-w. Epub 2020 Jan 2. PMID 31898172
BACKGROUNDMichie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42. PMID 21513547
BACKGROUNDMcCullough DJ, Stabley JN, Siemann DW, Behnke BJ. Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J Natl Cancer Inst. 2014 Apr;106(4):dju036. doi: 10.1093/jnci/dju036. Epub 2014 Mar 13. PMID 24627275
BACKGROUNDMacmillan (2023) Physical Activity and Cancer
BACKGROUNDLumivero (2017) NVivo (Version 12).
BACKGROUNDLigibel JA, Bohlke K, Alfano CM. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline Summary and Q&A. JCO Oncol Pract. 2022 Oct;18(10):695-697. doi: 10.1200/OP.22.00277. Epub 2022 Jul 5. No abstract available. PMID 35787022
BACKGROUNDLiu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023 Apr 12;8(1):160. doi: 10.1038/s41392-023-01419-2. PMID 37045827
BACKGROUNDLee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: 10.1186/1479-5868-8-115. PMID 22018588
BACKGROUNDKoller M, Musoro JZ, Tomaszewski K, Coens C, King MT, Sprangers MAG, Groenvold M, Cocks K, Velikova G, Flechtner HH, Bottomley A. Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. 2022 May;167:65-72. doi: 10.1016/j.lungcan.2022.03.018. Epub 2022 Mar 29. PMID 35413526
BACKGROUNDKirkham AA, Campbell KL, McKenzie DC. Comparison of aerobic exercise intensity prescription methods in breast cancer. Med Sci Sports Exerc. 2013 Aug;45(8):1443-50. doi: 10.1249/MSS.0b013e3182895195. PMID 23439424
BACKGROUNDKilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM. Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. J Geriatr Oncol. 2016 Jul;7(4):293-304. doi: 10.1016/j.jgo.2016.04.007. Epub 2016 May 31. PMID 27197916
BACKGROUNDKARVONEN MJ, KENTALA E, MUSTALA O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307-15. No abstract available. PMID 13470504
BACKGROUNDKallio H, Pietila AM, Johnson M, Kangasniemi M. Systematic methodological review: developing a framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016 Dec;72(12):2954-2965. doi: 10.1111/jan.13031. Epub 2016 Jun 23. PMID 27221824
BACKGROUNDHuffman MK, Christ SL, Ferraro KF, Klenosky DB, Marceau K, Amireault S. Questions to Measure Enjoyment of and Satisfaction With Physical Activity: Are They Appropriate for Use in an Older Population? Innov Aging. 2021 Oct 4;5(4):igab041. doi: 10.1093/geroni/igab041. eCollection 2021. PMID 34988294
BACKGROUNDHircock C, Wang AJ, Goonaratne E, Sferrazza D, Bottomley A, Cella D, Lee SF, Chan AW, Chow E, Wong HCY. Comparing the EORTC QLQ-LC13, EORTC QLQ-LC29, and the FACT-L for assessment of quality of life in patients with lung cancer - an updated systematic review. Curr Opin Support Palliat Care. 2024 Dec 1;18(4):260-268. doi: 10.1097/SPC.0000000000000725. Epub 2024 Oct 30. PMID 39269263
BACKGROUNDGraham-Wisener L, Dempster M, Sadler A, McCann L, McCorry NK. Validation of the Distress Thermometer in patients with advanced cancer receiving specialist palliative care in a hospice setting. Palliat Med. 2021 Jan;35(1):120-129. doi: 10.1177/0269216320954339. Epub 2020 Sep 11. PMID 32912055
BACKGROUNDEsteves M, Monteiro MP, Duarte JA. The Effects of Physical Exercise on Tumor Vasculature: Systematic Review and Meta-analysis. Int J Sports Med. 2021 Dec;42(14):1237-1249. doi: 10.1055/a-1533-1876. Epub 2021 Aug 2. PMID 34341974
BACKGROUNDEgegaard T, Rohold J, Lillelund C, Persson G, Quist M. Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study. Rep Pract Oncol Radiother. 2019 Jul-Aug;24(4):375-382. doi: 10.1016/j.rpor.2019.06.003. Epub 2019 Jun 21. PMID 31289452
BACKGROUNDDufresne S, Gueritat J, Chiavassa S, Noblet C, Assi M, Rioux-Leclercq N, Rannou-Bekono F, Lefeuvre-Orfila L, Paris F, Rebillard A. Exercise training improves radiotherapy efficiency in a murine model of prostate cancer. FASEB J. 2020 Apr;34(4):4984-4996. doi: 10.1096/fj.201901728R. Epub 2020 Feb 11. PMID 32043634
BACKGROUNDCormie P, Zopf EM, Zhang X, Schmitz KH. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017 Jan 1;39(1):71-92. doi: 10.1093/epirev/mxx007. PMID 28453622
BACKGROUNDColetta AM, Basen-Engquist KM, Schmitz KH. Exercise Across the Cancer Care Continuum: Why It Matters, How to Implement It, and Motivating Patients to Move. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-7. doi: 10.1200/EDBK_349635. PMID 35394822
BACKGROUNDCleland BT, Ingraham BA, Pitluck MC, Woo D, Ng AV. Reliability and Validity of Ratings of Perceived Exertion in Persons With Multiple Sclerosis. Arch Phys Med Rehabil. 2016 Jun;97(6):974-82. doi: 10.1016/j.apmr.2016.01.013. Epub 2016 Feb 1. PMID 26836954
BACKGROUNDChurch S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7. PMID 33028215
BACKGROUNDCella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995 Jun;12(3):199-220. doi: 10.1016/0169-5002(95)00450-f. PMID 7655830
BACKGROUNDCampbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116. PMID 31626055
BACKGROUNDBrown M, Rebillard A, Hart NH, O'Connor D, Prue G, O'Sullivan JM, Jain S. Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity. Sports Med Open. 2022 Apr 8;8(1):48. doi: 10.1186/s40798-022-00436-9. PMID 35394236
BACKGROUNDBradley, P., Merchant, Z., Rowlinson-Groves, K., Grundy, S., Al-Najjar, H., Brown, L., Dand, A., Farran, C., Bayman, N., Banfill, K., Wray, D., Moore, J. & Evison, M. (2021) 'P212 Prehab4Cancer: an innovative regional lung cancer prehabilitation service', Thorax, 76 (1), pp. A204-A205
BACKGROUNDBergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994;30A(5):635-42. doi: 10.1016/0959-8049(94)90535-5. PMID 8080679
BACKGROUNDBeale, L., Carter, H., Doust, J., Brickley, G., Silberbauer, J. & Llyod, G. (2010) 'Exercise heart rate guidelines overestimate recommended intensity for chronic heart failure patients', British Journal of Cardiology, 17, pp.133-137.
BACKGROUNDBarker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015 Jul;15(7):409-25. doi: 10.1038/nrc3958. PMID 26105538
BACKGROUNDBalachandran AT, Vigotsky AD, Quiles N, Mokkink LB, Belio MA, Glenn JM. Validity, reliability, and measurement error of a sit-to-stand power test in older adults: A pre-registered study. Exp Gerontol. 2021 Mar;145:111202. doi: 10.1016/j.exger.2020.111202. Epub 2020 Dec 19. PMID 33347922
BACKGROUNDAvancini A, Sartori G, Gkountakos A, Casali M, Trestini I, Tregnago D, Bria E, Jones LW, Milella M, Lanza M, Pilotto S. Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled? Oncologist. 2020 Mar;25(3):e555-e569. doi: 10.1634/theoncologist.2019-0463. Epub 2019 Nov 26. PMID 32162811
BACKGROUNDAtun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M. Expanding global access to radiotherapy. Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. PMID 26419354
BACKGROUNDAssociation of Chartered Physiotherapists in Cardiovascular Rehabilitation (2023) Standards for Physical Activity and Exercise in the Cardiovascular Population: 4th Edition
BACKGROUNDAaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365. PMID 8433390